Abstract
The hippocampal gamma oscillation is important for cognitive function, and its deficit is related to cognitive impairment in Alzheimer’s disease (AD). Recently, it has been recognized that post-translational modification via histone acetylation is a fundamental molecular mechanism for regulating synaptic plasticity and cognitive function. However, little is known regarding the regulation of hippocampal gamma oscillation by histone acetylation. We investigated whether histone acetylation regulated kainate-induced gamma oscillations and their important regulator, fast-spiking interneurons, using acute hippocampal slices of AD model mice (PSAPP transgenic mice). We found a decrease in kainate-induced gamma oscillations in slices from PSAPP mice, accompanied with the increased activity of fast spiking interneurons in basal state and the decreased activity in activated state. The histone deacetylase (HDAC) inhibitor (SAHA, named vorinostat) restored deficits of gamma oscillation in PSAPP mice, accompanied with rescue of activity of fast spiking interneurons in basal and activated state. The effect of SAHA was different from that of the clinical AD drug donepezil, which rescued only function of fast spiking interneurons in basal state. Besides, activator of nuclear receptor family 4a (NR4a) receptor (cytosporone B), as one of the epigenetic modification related to HDAC inhibition, rescued the deficits in gamma oscillations in PSAPP mice. These results suggested a novel mechanism in which HDAC inhibition improved impairment of gamma oscillations in PSAPP mice by restoring the activity of fast spiking interneurons both in basal and activated state. The reversal of gamma oscillation deficits by HDAC inhibition and/or NR4a activation appears to be a potential therapeutic target for treating cognitive impairment in AD patients.
Highlights
Alzheimer’s disease (AD) is the most common form of dementia, and patients with the disease experience progressive cognitive dysfunction (Selkoe, 2002; Walsh and Selkoe, 2007)
These results demonstrated that a deficit in gamma oscillations was observed in both PSAPP mice and aged PS mice
The average kainate-induced gamma power was significantly increased by cytosporone B (Figure 4C right panel, p < 0.001 at CA1, p < 0.01 at CA3, p < 0.05 at DG, n = 7). These results demonstrated that nuclear receptor family 4a (NR4a) activation as one of the epigenetic modification related to histone deacetylase (HDAC) inhibition rescued deficits in kainate-induced gamma oscillations in PSAPP mice
Summary
Alzheimer’s disease (AD) is the most common form of dementia, and patients with the disease experience progressive cognitive dysfunction (Selkoe, 2002; Walsh and Selkoe, 2007). It has recently become clear that understanding the influence of amyloid beta and its downstream molecular signals on the progressive alteration of synaptic function and neuronal network activity between multiple neurons is important for understanding cognitive dysfunction (Palop and Mucke, 2010). This is supported by evidence from multi-neuronal network analysis, including EEG recordings, in which both clinical patients and an animal model of AD exhibit cognitive dysfunction associated with aberrant neuronal network activity in the hippocampus and cortex (Herrmann and Demiralp, 2005; Verret et al, 2012; Hazra et al, 2013; Born et al, 2014; Igarashi et al, 2014). These results indicated a novel mechanism in which HDAC inhibition improved impairment of gamma oscillations in PSAPP mice by restoring activity of fast spiking interneurons both in basal and activated state
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
